FDA approves GSK’s Jideytro for ROS1-positive lung cancer
FDA approves GSK’s Jideytro for ROS1-positive lung cancer
FDA approves GSK’s Jideytro for ROS1-positive lung cancer
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.